The FDA recently approved Seglentis (Esteve Pharmaceuticals), a first-in-class product comprised of a co-crystal form of celecoxib (an anti-inflammatory drug) and tramadol (an analgesic) for the treatment of acute pain in adults.1-9
DECEMBER 13, 2021